Literature DB >> 20565482

Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?

Inga-Cecilie Sørheim1, Ane Johannessen, Thomas Blix Grydeland, Ernst Reidar Omenaas, Amund Gulsvik, Per Sigvald Bakke.   

Abstract

INTRODUCTION: Sampling is regarded as crucial to the validity of case-control studies. Ideally, cases and controls should be selected from the same source population, but deviations from this approach are often seen.
OBJECTIVE: Our objective was to examine how exposure-disease relationships in a study on chronic obstructive pulmonary disease (COPD) were affected by the sampling sources of cases and controls.
METHODS: A Norwegian case-control study on COPD including 1909 subjects used three sources of recruitment for cases (general population, hospital registry and volunteers) and two sources for controls (general population and volunteers). This resulted in six sampling combinations of cases and controls (groups A-F). We examined how the risk factors gender, age, smoking, educational level and comorbidity were associated with COPD in these six sampling groups.
RESULTS: Several exposure-disease associations were dependent on variation in sampling source, thereby demonstrating the possibility of selection bias. The theoretically most ideal sampling group is likely group A, where both cases and controls are recruited from a general population. When using group A as a reference, the groups containing either voluntary controls and/or hospital-based cases deviated the most, suggesting higher susceptibility to selection bias in these groups.
CONCLUSION: Recruitment from several sources made our study design vulnerable to selection bias. Our findings should bring about increased awareness to the sampling process, and encourage sampling of cases and controls from the same source population in future studies.

Entities:  

Mesh:

Year:  2010        PMID: 20565482     DOI: 10.1111/j.1752-699X.2009.00154.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  11 in total

1.  Gender differences in COPD: are women more susceptible to smoking effects than men?

Authors:  Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

2.  Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects.

Authors:  Robert Busch; Brian D Hobbs; Jin Zhou; Peter J Castaldi; Michael J McGeachie; Megan E Hardin; Iwona Hawrylkiewicz; Pawel Sliwinski; Jae-Joon Yim; Woo Jin Kim; Deog K Kim; Alvar Agusti; Barry J Make; James D Crapo; Peter M Calverley; Claudio F Donner; David A Lomas; Emiel F Wouters; Jørgen Vestbo; Ruth Tal-Singer; Per Bakke; Amund Gulsvik; Augusto A Litonjua; David Sparrow; Peter D Paré; Robert D Levy; Stephen I Rennard; Terri H Beaty; John Hokanson; Edwin K Silverman; Michael H Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

3.  A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

Authors:  Michael H Cho; Peter J Castaldi; Emily S Wan; Mateusz Siedlinski; Craig P Hersh; Dawn L Demeo; Blanca E Himes; Jody S Sylvia; Barbara J Klanderman; John P Ziniti; Christoph Lange; Augusto A Litonjua; David Sparrow; Elizabeth A Regan; Barry J Make; John E Hokanson; Tanda Murray; Jacqueline B Hetmanski; Sreekumar G Pillai; Xiangyang Kong; Wayne H Anderson; Ruth Tal-Singer; David A Lomas; Harvey O Coxson; Lisa D Edwards; William MacNee; Jørgen Vestbo; Julie C Yates; Alvar Agusti; Peter M A Calverley; Bartolome Celli; Courtney Crim; Stephen Rennard; Emiel Wouters; Per Bakke; Amund Gulsvik; James D Crapo; Terri H Beaty; Edwin K Silverman
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

4.  Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD.

Authors:  Erica P A Rutten; Thomas B Grydeland; Sreekumar G Pillai; Scott Wagers; Asger Dirksen; Harvey O Coxson; Amund Gulsvik; Emiel F M Wouters; Per S Bakke
Journal:  Pulm Med       Date:  2011-01-16

5.  Productivity losses in chronic obstructive pulmonary disease: a population-based survey.

Authors:  Marta Erdal; Ane Johannessen; Jan Erik Askildsen; Tomas Eagan; Amund Gulsvik; Rune Grønseth
Journal:  BMJ Open Respir Res       Date:  2014-12-01

6.  Motivation and response rates in bronchoscopy studies.

Authors:  Einar M H Martinsen; Tomas M L Eagan; Elise O Leiten; Eli Nordeide; Per S Bakke; Sverre Lehmann; Rune Nielsen
Journal:  Multidiscip Respir Med       Date:  2019-05-02

7.  Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.

Authors:  Lan Ai Kieu Le; Ane Johannessen; Jon Andrew Hardie; Odd Erik Johansen; Amund Gulsvik; Bjørn Egil Vikse; Per Bakke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-23

8.  The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences.

Authors:  Rune Grønseth; Ingvild Haaland; Harald G Wiker; Einar Marius H Martinsen; Elise O Leiten; Gunnar Husebø; Øistein Svanes; Per S Bakke; Tomas M Eagan
Journal:  Eur Clin Respir J       Date:  2014-12-29

9.  Complications and discomfort after research bronchoscopy in the MicroCOPD study.

Authors:  Elise Orvedal Leiten; Tomas Mikal Lind Eagan; Einar Marius Hjellestad Martinsen; Eli Nordeide; Gunnar Reksten Husebø; Kristel Svalland Knudsen; Sverre Lehmann; Øistein Svanes; Per Sigvald Bakke; Rune Nielsen
Journal:  BMJ Open Respir Res       Date:  2020-03

10.  Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.

Authors:  Matthew Moll; Phuwanat Sakornsakolpat; Nick Shrine; Brian D Hobbs; Dawn L DeMeo; Catherine John; Anna L Guyatt; Michael J McGeachie; Sina A Gharib; Ma'en Obeidat; Lies Lahousse; Sara R A Wijnant; Guy Brusselle; Deborah A Meyers; Eugene R Bleecker; Xingnan Li; Ruth Tal-Singer; Ani Manichaikul; Stephen S Rich; Sungho Won; Woo Jin Kim; Ah Ra Do; George R Washko; R Graham Barr; Bruce M Psaty; Traci M Bartz; Nadia N Hansel; Kathleen Barnes; John E Hokanson; James D Crapo; David Lynch; Per Bakke; Amund Gulsvik; Ian P Hall; Louise Wain; Scott T Weiss; Edwin K Silverman; Frank Dudbridge; Martin D Tobin; Michael H Cho
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 102.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.